DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension

NCT00330369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Darusentan
DRUG: Darusentan Placebo

Sponsor

Gilead Sciences